Covid-19: Pfizer recommended for vaccine booster

The Haute Autorité de santé recommends not using Moderna’s vaccine for the third dose.

At the beginning of September, the vaccine booster campaign against the Covid began. Intended globally for people at risk (over 65 years, people with comorbidities at risk of a severe form, nursing and medico-social personnel, immunocompromised and their entourage), these reminders have started to be carried out with doses of mRNA vaccines, regardless of firms Pfizer / BioNTech (Comirnaty) or Moderna (Spikevax). The High Authority for Health, which issues recommendations on drugs in France, has however just published an opinion in which it advises not to use the latter as a reminder for the moment and to stick, in this indication, to the Comirnaty, already in the majority in our country.

Behind this turnaround, the decision, on October 6, of Sweden, Finland, Norway and Denmark to at least temporarily suspend the vaccination of children under 30 or 18 with Moderna’s vaccine. The Scandinavians invoked a “precautionary measure” taken on the basis

This article is for subscribers only. You have 66% left to discover.

Pushing back the limits of science is also freedom.

Continue reading your article for € 1 the first month

Already subscribed? Log in


Leave a Reply

Your email address will not be published. Required fields are marked *